Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line

Biochemical and Biophysical Research Communications

Volumn 365, Issue 1, 2008, Pages 164-169

  Sakudo, Akikazu ^a   Wu, Guoying ^b   Onodera, Takashi ^b   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Prion protein; PrP gene deficient cell line; PrPSc

Indexed keywords

ISOPROTEIN; PRION PROTEIN; PROTEINASE K;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HYDROPHOBICITY; NERVE CELL; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN STRUCTURE; WILD TYPE;

ANIMALS; CATTLE; CELL LINE; NEURONS; OLIGOPEPTIDES; PRIONS; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS; REPETITIVE SEQUENCES, AMINO ACID;

EID: 36048993416     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.158     Document Type: Article

References (40)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 95 (1998) 13363-13383
2. Sakudo A., Onodera T., Suganuma Y., Kobayashi T., Saeki K., and Ikuta K. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini. Rev. Med. Chem. 6 (2006) 589-601
3. Gasset M., Baldwin M.A., Fletterick R.J., and Prusiner S.B. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc. Natl. Acad. Sci. USA 90 (1993) 1-5
4. Sakudo A., Nakamura I., Ikuta K., and Onodera T. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models. J. Vet. Med. Sci. 69 (2007) 329-337
5. Barron R.M., Thomson V., Jamieson E., Melton D.W., Ironside J., Will R., and Manson J.C. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 20 (2001) 5070-5078
6. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., and Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
7. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., and Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15 (1996) 1255-1264
8. Flechsig E., Shmerling D., Hegyi I., Raeber A.J., Fischer M., Cozzio A., von Mering C., Aguzzi A., and Weissmann C. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27 (2000) 399-408
9. Perrier V., Kaneko K., Safar J., Vergara J., Tremblay P., DeArmond S.J., Cohen F.E., Prusiner S.B., and Wallace A.C. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 13079-13084
10. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., and Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73 (1993) 979-988
11. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A., von Mering C., Hangartner C., Aguzzi A., and Weissmann C. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 (1998) 203-314
12. Telling G.C., Scott M., Hsiao K.K., Foster D., Yang S.L., Torchia M., Sidle K.C., Collinge J., DeArmond S.J., and Prusiner S.B. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. USA 91 (1994) 9936-9940
13. Brun A., Gutierrez-Adan A., Castilla J., Pintado B., Diaz-San Segundo F., Cano M.J., Alamillo E., Espinosa J.C., and Torres J.M. Reduced susceptibility to bovine spongiform encephalopathy prions in transgenic mice expressing a bovine PrP with five octapeptide repeats. J. Gen. Virol. 88 (2007) 1842-1849
14. Rogers M., Yehiely F., Scott M., and Prusiner S.B. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90 (1993) 3182-3186
15. Kaneko K., Zulianello L., Scott M., Cooper C.M., Wallace A.C., James T.L., Cohen F.E., and Prusiner S.B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94 (1997) 10069-10074
16. Kaneko K., Vey M., Scott M., Pilkuhn S., Cohen F.E., and Prusiner S.B. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl. Acad. Sci. USA 94 (1997) 2333-2338
17. Race R.E., Caughey B., Graham K., Ernst D., and Chesebro B. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J. Virol. 62 (1988) 2845-2849
18. Race R.E., Priola S.A., Bessen R.A., Ernst D., Dockter J., Rall G.F., Mucke L., Chesebro B., and Oldstone M.B. Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron 15 (1995) 1183-1191
19. Raeber A.J., Race R.E., Brandner S., Priola S.A., Sailer A., Bessen R.A., Mucke L., Manson J., Aguzzi A., Oldstone M.B., Weissmann C., and Chesebro B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16 (1997) 6057-6065
20. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S.J., et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59 (1989) 847-857
21. Vilette D., Andreoletti O., Archer F., Madelaine M.F., Vilotte J.L., Lehmann S., and Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. USA 98 (2001) 4055-4059
22. Sakudo A., Onodera T., and Ikuta K. Prion protein gene-deficient cell lines: powerful tools for prion biology. Microbiol. Immunol. 51 (2007) 1-13
23. Kim C.L., Karino A., Ishiguro N., Shinagawa M., Sato M., and Horiuchi M. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol. 85 (2004) 3473-3482
24. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S., and Onodera T. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
25. Sakudo A., Lee D.C., Saeki K., Nakamura Y., Inoue K., Matsumoto Y., Itohara S., and Onodera T. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 308 (2003) 660-667
26. Sakudo A., Lee D.C., Nishimura T., Li S., Tsuji S., Nakamura T., Matsumoto Y., Saeki K., Itohara S., Ikuta K., and Onodera T. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem. Biophys. Res. Commun. 326 (2005) 600-606
27. Sakudo A., Nakamura I., Lee D.C., Saeki K., Ikuta K., and Onodera T. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line. Protein Pept. Lett. 14 (2007) 1-6
28. Sakudo A., Lee D.C., Saeki K., Matsumoto Y., Itohara S., and Onodera T. Tumor necrosis factor attenuates prion protein-deficient neuronal cell death by increases in anti-apoptotic Bcl-2 family proteins. Biochem. Biophys. Res. Commun. 310 (2003) 725-729
29. Barret A., Tagliavini F., Forloni G., Bate C., Salmona M., Colombo L., De Luigi A., Limido L., Suardi S., Rossi G., Auvre F., Adjou K.T., Sales N., Williams A., Lasmezas C., and Deslys J.P. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77 (2003) 8462-8469
30. Saborio G.P., Permanne B., and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 (2001) 810-813
31. Maas E., Geissen M., Groschup M.H., Rost R., Onodera T., Schatzl H., and Vorberg I.M. Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. J. Biol. Chem. 282 (2007) 18702-18712
32. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., Fraser P.E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., and Kretzschmar H. The cellular prion protein binds copper in vivo. Nature 390 (1997) 684-687
33. Daude N., Marella M., and Chabry J. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J. Cell Sci. 116 (2003) 2775-2779
34. Jackson G.S., Murray I., Hosszu L.L., Gibbs N., Waltho J.P., Clarke A.R., and Collinge J. Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. USA 98 (2001) 8531-8535
35. Kim N.H., Choi J.K., Jeong B.H., Kim J.I., Kwon M.S., Carp R.I., and Kim Y.S. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J. 19 (2005) 783-785
36. Tagliavini F., Prelli F., Verga L., Giaccone G., Sarma R., Gorevic P., Ghetti B., Passerini F., Ghibaudi E., Forloni G., et al. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 90 (1993) 9678-9682
37. Selvaggini C., De Gioia L., Cantu L., Ghibaudi E., Diomede L., Passerini F., Forloni G., Bugiani O., Tagliavini F., and Salmona M. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194 (1993) 1380-1386
38. O'Donovan C.N., Tobin D., and Cotter T.G. Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J. Biol. Chem. 276 (2001) 43516-43523
39. Onoue S., Ohshima K., Endo K., Yajima T., and Kashimoto K. PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106-126. FEBS Lett. 522 (2002) 65-70
40. Solassol J., Crozet C., and Lehmann S. Prion propagation in cultured cells. Br. Med. Bull 66 (2003) 87-97